{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:04:19Z","timestamp":1793833459065,"version":"4.6.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Traumatic brain injury (TBI) is an expensive and common public health problem. Management of TBI oftentimes includes sedation to facilitate mechanical ventilation (MV) for airway protection. Dexmedetomidine has emerged as a potential candidate for improved patient outcomes when used for early sedation after TBI due to its potential modulation of autonomic dysfunction. We examined early sedation patterns, as well as the association of dexmedetomidine exposure with clinical and functional outcomes among mechanically ventilated patients with moderate-severe TBI (msTBI) in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using data from the Premier dataset and identified a cohort of critically ill adult patients with msTBI who required MV from January 2016 to June 2020. msTBI was defined by head-neck abbreviated injury scale (AIS) values of 3 (serious), 4 (severe), and 5 (critical). We described early continuous sedative utilization patterns. Using propensity-matched models, we examined the association of early dexmedetomidine exposure (within 2 days of intensive care unit [ICU] admission) with the primary outcome of hospital mortality and the following secondary outcomes: hospital length of stay (LOS), days on MV, vasopressor use after the first 2 days of admission, hemodialysis (HD) after the first 2 days of admission, hospital costs, and discharge disposition. All medications, treatments, and procedures were identified using date-stamped hospital charge codes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The study population included 19,751 subjects who required MV within 2 days of ICU admission. The patients were majority male and white. From 2016 to 2020, the annual percent utilization of dexmedetomidine increased from 4.05% to 8.60%. After propensity score matching, early dexmedetomidine exposure was associated with reduced odds of hospital mortality (odds ratio [OR], 0.59; 95% confidence interval [CI], 0.47\u20130.74;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001), increased risk for liberation from MV (hazard ratio [HR], 1.20; 95% CI, 1.09\u20131.33;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0003), and reduced LOS (HR, 1.11; 95% CI, 1.01\u20131.22;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .033). Exposure to early dexmedetomidine was not associated with odds of HD (OR, 1.14; 95% CI, 0.73\u20131.78;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .56), vasopressor utilization (OR, 1.10; 95% CI, 0.78\u20131.55;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .60), or increased hospital costs (relative cost ratio, 1.98; 95% CI, 0.93\u20131.03;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .66).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Dexmedetomidine is being utilized increasingly as a sedative for mechanically ventilated patients with msTBI. Early dexmedetomidine exposure may lead to improved patient outcomes in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000006869","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T13:36:50Z","timestamp":1707485810000},"page":"366-374","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Association of Early Dexmedetomidine Utilization With Clinical Outcomes After Moderate-Severe Traumatic Brain Injury: A Retrospective Cohort Study"],"prefix":"10.1213","volume":"139","author":[{"given":"Sunny Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Kelly-Hedrick","sequence":"additional","affiliation":[{"name":"Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, North Carolina"},{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Komisarow","sequence":"additional","affiliation":[{"name":"Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, North Carolina"},{"name":"Neurosurgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Hatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Ohnuma","sequence":"additional","affiliation":[{"name":"Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, North Carolina"},{"name":"Anesthesiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam M.","family":"Treggiari","sequence":"additional","affiliation":[{"name":"Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, North Carolina"},{"name":"Anesthesiology"},{"name":"Population Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Colton","sequence":"additional","affiliation":[{"name":"Neurology, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangeline","family":"Arulraja","sequence":"additional","affiliation":[{"name":"Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica S.","family":"Vavilala","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Laskowitz","sequence":"additional","affiliation":[{"name":"Neurology, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Mathew","sequence":"additional","affiliation":[{"name":"Anesthesiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"James","sequence":"additional","affiliation":[{"name":"Anesthesiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Raghunathan","sequence":"additional","affiliation":[{"name":"Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, North Carolina"},{"name":"Anesthesiology"},{"name":"Population Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Krishnamoorthy","sequence":"additional","affiliation":[{"name":"Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University, Durham, North Carolina"},{"name":"Anesthesiology"},{"name":"Population Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury.","volume":"130","author":"Dewan","year":"2018","journal-title":"J Neurosurg"},{"key":"R2-20250502","article-title":"In-hospital costs after severe traumatic brain injury: a systematic review and quality assessment.","volume":"14","author":"Kerezoudis","year":"2019","journal-title":"PLoS One"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/CCM.0000000000005055","article-title":"Association of early multiple organ dysfunction with clinical and functional outcomes over the year following traumatic brain injury: a transforming research and clinical knowledge in Traumatic Brain Injury Study.","volume":"49","author":"Krishnamoorthy","year":"2021","journal-title":"Crit Care Med"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/TA.0000000000002562","article-title":"Effects of hospital-acquired pneumonia on long-term recovery and hospital resource utilization following moderate to severe traumatic brain injury.","volume":"88","author":"Kumar","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU.","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"637171","DOI":"10.1155\/2012\/637171","article-title":"Sedation in traumatic brain injury.","volume":"2012","author":"Flower","year":"2012","journal-title":"Emerg Med Int"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1097\/CCM.0b013e318228236f","article-title":"Sedation for critically ill adults with severe traumatic brain injury: a systematic review of randomized controlled trials.","volume":"39","author":"Roberts","year":"2011","journal-title":"Crit Care Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the management of severe traumatic brain injury, fourth edition.","volume":"80","author":"Carney","year":"2017","journal-title":"Neurosurgery"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1097\/TA.0b013e3182701885","article-title":"Evaluation and management of mild traumatic brain injury.","volume":"73","author":"Barbosa","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/ANA.0000000000000836","article-title":"The impact of sedative choice on intracranial and systemic physiology in moderate to severe traumatic brain injury: a scoping review.","volume":"35","author":"Jeffcote","year":"2022","journal-title":"J Neurosurg Anesthesiol"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/anae.15621","article-title":"Pragmatic sedation strategies to prevent secondary brain injury in low-resource settings.","volume":"77","author":"Kayambankadzanja","year":"2022","journal-title":"Anaesthesia"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1055\/s-0028-1105970","article-title":"Sedation and pain management in acute neurological disease.","volume":"28","author":"Mirski","year":"2008","journal-title":"Semin Neurol"},{"key":"R13-20250502","article-title":"Safety, efficacy, and clinical outcomes of dexmedetomidine for sedation in traumatic brain injury: a Scoping Review.","author":"Hatfield","year":"2023","journal-title":"J Neurosurg Anesthesiol"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40621-018-0149-8","article-title":"Open-access programs for injury categorization using ICD-9 or ICD-10.","volume":"5","author":"Clark","year":"2018","journal-title":"Inj Epidemiol"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00005373-197403000-00001","article-title":"The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care.","volume":"14","author":"Baker","year":"1974","journal-title":"J Trauma"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/archsurg.136.10.1118","article-title":"Hypotension, hypoxia, and head injury.","volume":"136","author":"Manley","year":"2001","journal-title":"Arch Surg"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MLR.0000000000000326","article-title":"A new Elixhauser-based comorbidity summary measure to predict in-hospital mortality.","volume":"53","author":"Thompson","year":"2015","journal-title":"Med Care"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"21687","DOI":"10.18632\/aging.103975","article-title":"Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b\/miR-27a-3p\/Dram2 pathway in a rat model of traumatic brain injury.","volume":"12","author":"Li","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.chest.2021.01.016","article-title":"Multiorgan dysfunction after severe traumatic brain injury: epidemiology, mechanisms, and clinical management.","volume":"160","author":"Krishnamoorthy","year":"2021","journal-title":"Chest"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jclinane.2017.04.003","article-title":"The protective effects of dexmedetomidine on ischemic brain injury: a meta-analysis.","volume":"40","author":"Jiang","year":"2017","journal-title":"J Clin Anesth"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s00134-007-0974-7","article-title":"Extracranial complications in patients with acute brain injury: a post-hoc analysis of the SOAP study.","volume":"34","author":"Mascia","year":"2008","journal-title":"Intensive Care Med"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3171\/jns.1984.61.1.0076","article-title":"Mechanical brain injury: the sympathoadrenal response.","volume":"61","author":"Rosner","year":"1984","journal-title":"J Neurosurg"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1001\/jama.298.22.2644","article-title":"Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients.","volume":"298","author":"Pandharipande","year":"2007","journal-title":"JAMA"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/cc8916","article-title":"Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial.","volume":"14","author":"Pandharipande","year":"2010","journal-title":"Critical Care"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12028-021-01298-x","article-title":"A one-day prospective national observational study on sedation-analgesia of patients with brain injury in French intensive care units: the SEDA-BIP-ICU (Sedation-Analgesia in Brain Injury Patient in ICU) Study.","volume":"36","author":"Poignant","year":"2021","journal-title":"Neurocrit Care"},{"key":"R29-20250502","first-page":"319","article-title":"Early sedation in traumatic brain injury: a multicentre international observational study journal article.","volume":"24","author":"Russo","year":"2022","journal-title":"Crit Care Resusc"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.accpm.2015.06.012","article-title":"Efficacy and safety of sedation with dexmedetomidine in critical care patients: a meta-analysis of randomized controlled trials.","volume":"35","author":"Constantin","year":"2016","journal-title":"Anaesth Crit Care Pain Med"},{"key":"R31-20250502","first-page":"CD010269","article-title":"Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients.","volume":"1","author":"Chen","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00134-022-06712-2","article-title":"Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials.","volume":"48","author":"Lewis","year":"2022","journal-title":"Intensive Care Med"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12028-017-0388-5","article-title":"A systematic review of alpha-2 agonists for sedation in mechanically ventilated neurocritical care patients.","volume":"28","author":"Tran","year":"2018","journal-title":"Neurocrit Care"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2147\/CEOR.S242994","article-title":"Cost-minimization analysis of dexmedetomidine compared to other sedatives for short-term sedation during mechanical ventilation in the United States.","volume":"12","author":"Aggarwal","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"key":"R35-20250502","doi-asserted-by":"crossref","DOI":"10.1186\/s12871-022-01822-2","article-title":"Assessment of the effects of dexmedetomidine on outcomes of traumatic brain injury using propensity score analysis.","volume":"22","author":"Xu","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/TA.0000000000001069","article-title":"Dexmedetomidine as an adjunct for sedation in patients with traumatic brain injury.","volume":"81","author":"Pajoumand","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"R37-20250502","doi-asserted-by":"crossref","DOI":"10.5137\/1019-5149.JTN.36585-21.2","article-title":"Clinical study of dexmedetomidine in combination with butorphanol for the treatment of postoperative traumatic brain injury (TBI).","author":"Xuejian","year":"2022","journal-title":"Turk Neurosurg"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jcph.1539","article-title":"Use of propofol plus dexmedetomidine in patients experiencing severe alcohol withdrawal in the intensive care unit.","volume":"60","author":"Love","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12028-007-0066-0","article-title":"Dexmedetomidine for the treatment of paroxysmal autonomic instability with dystonia.","volume":"7","author":"Goddeau","year":"2007","journal-title":"Neurocrit Care"},{"key":"R40-20250502","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2710.2008.00883.x","article-title":"Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit.","volume":"33","author":"Arpino","year":"2008","journal-title":"J Clin Pharm Ther"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:38Z","timestamp":1786112798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000006869","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,15]]}}}